Objective: To assess the proportion of female childhood and adolescent tumor survivors who could benefit from oocyte cryopreservation. Design: Case series of female childhood and adolescent tumor survivors referred for fertility counseling. Setting: A referral cancer center and an infertility unit of an academic hospital. Patient(s): Young female childhood and adolescent tumor survivors who received gonadotoxic treatments. Intervention(s): Patients were prescribed tests of ovarian reserve and a personalized counseling was given. Oocyte cryopreservation was considered in subjects aged ≥18 years who were diagnosed with diminished ovarian reserve (DOR) (antimüllerian hormone level <2 ng/mL or total antral follicle count ≤10). Main Outcome Measure(s): Rate of women with DOR who stored their oocytes. Result(s): Ninety out of 126 evaluated women completed the assessments. We documented preserved ovarian reserve, DOR, and premature ovarian insufficiency in 36 (40%), 35 (39%), and 19 (21%) cases, respectively. Overall, 13 subjects with DOR were eligible for oocyte cryostorage, of whom 9 (69%) underwent the procedure. Considering the whole cohort of evaluated young women (n = 90), the rate of those who had egg freezing was 10%. Finally, nine women started seeking pregnancy after the counseling (six with DOR), and seven of them became pregnant. When the data were analyzed separately according to most gonadotoxic treatments, considerable differences emerged but the evidence did not support the idea that counseling should be restricted to particular subgroups of women. Conclusion(s): Ovarian reserve impairment is common in female childhood and adolescent tumor survivors. Postcancer oocyte cryopreservation may be part of the armamentarium of fertility preservation options.
Fertility preservation in childhood and adolescent female tumor survivors / F. Filippi, C. Meazza, E. Somigliana, M. Podda, C. Dallagiovanna, M. Massimino, F. Raspagliesi, M. Terenziani. - In: FERTILITY AND STERILITY. - ISSN 0015-0282. - 116:4(2021 Oct), pp. 1087-1095. [10.1016/j.fertnstert.2021.06.012]
Fertility preservation in childhood and adolescent female tumor survivors
E. Somigliana
;C. Dallagiovanna;M. TerenzianiUltimo
2021
Abstract
Objective: To assess the proportion of female childhood and adolescent tumor survivors who could benefit from oocyte cryopreservation. Design: Case series of female childhood and adolescent tumor survivors referred for fertility counseling. Setting: A referral cancer center and an infertility unit of an academic hospital. Patient(s): Young female childhood and adolescent tumor survivors who received gonadotoxic treatments. Intervention(s): Patients were prescribed tests of ovarian reserve and a personalized counseling was given. Oocyte cryopreservation was considered in subjects aged ≥18 years who were diagnosed with diminished ovarian reserve (DOR) (antimüllerian hormone level <2 ng/mL or total antral follicle count ≤10). Main Outcome Measure(s): Rate of women with DOR who stored their oocytes. Result(s): Ninety out of 126 evaluated women completed the assessments. We documented preserved ovarian reserve, DOR, and premature ovarian insufficiency in 36 (40%), 35 (39%), and 19 (21%) cases, respectively. Overall, 13 subjects with DOR were eligible for oocyte cryostorage, of whom 9 (69%) underwent the procedure. Considering the whole cohort of evaluated young women (n = 90), the rate of those who had egg freezing was 10%. Finally, nine women started seeking pregnancy after the counseling (six with DOR), and seven of them became pregnant. When the data were analyzed separately according to most gonadotoxic treatments, considerable differences emerged but the evidence did not support the idea that counseling should be restricted to particular subgroups of women. Conclusion(s): Ovarian reserve impairment is common in female childhood and adolescent tumor survivors. Postcancer oocyte cryopreservation may be part of the armamentarium of fertility preservation options.File | Dimensione | Formato | |
---|---|---|---|
Filippi et al, Completo per Air.pdf
accesso aperto
Tipologia:
Pre-print (manoscritto inviato all'editore)
Dimensione
273.64 kB
Formato
Adobe PDF
|
273.64 kB | Adobe PDF | Visualizza/Apri |
1-s2.0-S0015028221005069-main.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
236.42 kB
Formato
Adobe PDF
|
236.42 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.